Apoptosis during bone-like tissue development in vitro

Journal of Cellular Biochemistry

Volumn 68, Issue 1, 1998, Pages 31-49

  Lynch, Maureen P ^a,b   Capparelli, Casey ^a   Stein, Janet L ^a   Stein, Gary S ^a   Lian, Jane B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Bax; Bcl 2; Bcl X; Bone; c fos; Collagenase gene expression; Differentiation; IRF 1; IRF 2; Msx 2; p53; Programmed cell death

Indexed keywords

DNA; INTERFERON; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN KINASE; PROTEIN P53; RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MINERALIZATION; BONE TISSUE; CALVARIA; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GENE EXPRESSION; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 0002175566     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980101)68:1<31::AID-JCB4>3.0.CO;2-X     Document Type: Article

References (109)

1. Alnemri ES, Fernandes TF, Haldar S, Croce CM, Litwack G (1992): Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 52:491-495.
2. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB (1990): Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:213-221.
3. Aubin JE, Turksen K, Heersche JNM (1993): Osteoblastic cell lineage. In Noda M (ed): "Cellular and Molecular Biology of Bone." San Diego: Academic Press, pp 1-45.
4. Ausubel FM, Brent R, Kingston RE, Moore DE, Seidman JG, Smith JA, Struhl K. (1989): "Current Protocols in Molecular Biology." New York: Greene and Wiley.
5. Baserga CG, Malamud D (1969): "Autoradiography." New York: Hoeber.
6. Batistatou A, Greene LA (1993): Internucleosomal cleavage and neuronal survival/death. J Cell Biol 122:523-532.
7. Bell JR, Noveen A, Liu YH, Ma L, Dobias S, Kundu R, Luo W, Xia Y, Lusis AJ, Snead ML, Maxson R (1993): Genomic structure, chromosomal location, and evolution of the mouse Hox 8 gene. Genomics 16:123-131.
8. Birnbaum RS, Wiren DM (1994): Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 135:223-230.
9. Bissonette RP, Echeverri F, Mahabubi A, Green DR (1992): Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
10. Boise LH, González-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB (1993): bcl-x a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
11. Boudreau N, Sympson CJ, Werb Z, Bissell MJ (1995): Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
12. Boyce BF (1996): Role of apoptosis in local regulation. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 739-753.
13. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB (1994): TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335.
14. Bronckers ALJJ, Goei W, Luo G, Karsenty G, D'Souza RN, Lyaruu DM, Burger EH (1996a): DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res 11:1281-1291.
15. Bronckers ALJJ, Lyaruu DM, Goei W, Litz M, Luo G, Karsenty G, Wöltgens JHM, D'Souza RN (1996b): Nuclear DNA fragmentation during postnatal tooth development of mouse and hamster and during dentin repair in the rat. Eur J Oral Sci 104:102-111.
16. Catron KM, Iler N, Abate C (1993): Nucleotides flanking a conserved TAAT core dictate the DNA binding specificity of three murine homeodomain proteins. Mol Cell Biol 13:2354-2365.
17. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ (1995): Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828.
18. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ (1979): Isolation and biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
19. Clark G (1981): Miscellaneous stains. In Clark G (ed): "Staining Procedures." Baltimore: Williams and Wilkins, pp 187.
20. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993): Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
21. Clarke PGH (1990): Developmental cell death: Morphological diversity and multiple mechanisms. Anat Embryol 181:195-213.
22. Coelho CND, Sumoy L, Rodgers BJ, Davidson DR, Hill RE, Upholt WB, Kosher RA (1991): Expression of the chicken homeobox-containing gene GHox-8 during embryonic chick limb development. Mech Dev 34:143-154.
23. Colotta F, Polentarutti N, Sironi M, Mantovani A (1992): Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267: 18278-18283.
24. Compton MM, Cidlowski JA (1992): Thymocyte apoptosis. A model of programmed cell death. Trends Endocrinol Metab 3:17-23.
25. Davidson DR, Crawley A, Hill RE, Tickle C (1991): Position-dependent expression of two related homeobox genes in developing vertebrate limbs. Nature 352:429-431.
26. Donehower LA, Bradley A (1993): The tumor suppressor p53. Biochim Biophys Acta 1155:181-205.
27. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A (1992): Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
28. Duke RC, Cohen JJ (1986): IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289-299.
29. Earnshaw WC (1995): Nuclear changes in apoptosis. Curr Opin Cell Biol 7:337-343.
30. Flaws JA, Kugu K, Trbovich AM, DeSanti A, Tilly KI, Hirshfield AN, Tilly JL (1995): Interleukin-1 beta-converting enzyme-related proteases (IRPs) and mammalian cell death: Dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 136: 5042-5053.
31. Frost HM (1960): In vivo osteocyte death. J Bone Joint Surg 42A:138-143.
32. Garcia-Martinez V, Macias D, Ganan Y, Garcia-Lobo JM, Francia MV, Fernandez-Teran MA, Hurle JM (1993): Internucleosomal DNA fragmentation and programmed cell death (apoptosis) in the interdigital tissue of the embryonic chick leg bud. J Cell Sci 106:201-208.
33. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992): Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
34. Gibson GJ, Kohler WJ, Schaffler MB (1995): Chondrocyte apoptosis in endochondral ossification of chick sterna. Dev Dyn 203:468-476.
35. Gottschalk AR, Boise LH, Thompson CB, Quintans J (1994): Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350-7354.
36. Graham A, Heyman I, Lumsden A (1993): Even-numbered rhombomeres control the apoptotic elimination of neural crest cells from odd-numbered rhombomeres in the chick hindbrain. Development 119:233-245.
37. Grigoriadis AE, Schellander K, Wang Z-Q, Wagner EF (1993): Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701.
38. Gundberg CM, Hauschka PV, Lian JB, Gallop PM (1984): Osteocalcin isolation, characterization, and detection. Methods Enzymol 107:516-544.
39. Hammar SP, Mottet NK (1971): Tetrazolium salt and electron-microscopic studies of cellular degeneration and necrosis in the interdigital areas of the developing chick limb. J Cell Sci 8:229-251.
40. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T (1993): Anti-oncogenic and oncogenic potentials of interferon regulatory factors -1 and -2. Science 259:971-974.
41. Hatori M, Klatte KJ, Teixeira CC, Shapiro IM (1995): End labeling studies of fragmented DNA in the avian growth plate: Evidence of apoptosis in terminally differentiated chondrocytes. J Bone Miner Res 10:1960-1968.
42. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M (1986): Growth factors in bone matrix. J Biol Chem 261:12665-12674.
43. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993): Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
44. Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS, Stein JL (1994): Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci USA 91:12887-12891.
45. Hoffmann HM, Beumer TL, Rahman S, McCabe LR, Banerjee C, Aslam F, Tiro JA, van Wijnen AJ, Stein JL, Stein GS, Lian JB (1996): Bone tissue-specific transcription of the osteocalcin gene: Role of an activator osteoblast-specific complex and suppressor hox proteins that bind the OC box. J Cell Biochem 61:310-324.
46. Hopwood D, Levison DA (1976): Atrophy and apoptosis in the cyclical human endometrium. J Pathol 119:159-166.
47. Hunter T, Pines J (1994): Cyclins and cancer II: Cyclin D and cdk inhibitors come of age. Cell 79:573-582.
48. Ishizaki Y, Cheng L, Mudge AW, Raff MC (1995): Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol Cell 6:1443-1458.
49. Itoh S, Harada H, Fujita T, Mimura T, Taniguchi T (1989): Sequence of a cDNA coding for human IRF-2. Nucleic Acids Res 17:8372.
50. Jande SS, Bélanger LF (1973): The life cycle of the osteocyte. Clin Orthop 94:281-305.
51. Kastan MB (1993): p53: Evolutionally conserved and constantly evolving. J NIH Res 5:53-57.
52. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991): Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
53. Kerr JFR, Wyllie AH, Currie AR (1972): Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 24:239-257.
54. Korsmeyer SJ (1992a): Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886.
55. Korsmeyer SJ (1992b): Bcl-2: An antidote to programmed cell death. Cancer Surveys 15:105-118.
56. Kyprianou N, Isaacs JT (1988): Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562.
57. Lane DP (1992): Cancer. p53, guardian of the genome. Nature 358:15-16.
58. Lee KK, Chan WY, Sze LY (1993): Histogenetic potential of rat hind-limb interdigital tissues prior to and during the onset of programmed cell death. Anat Rec 236:568-572.
59. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G (1989): Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147.
60. Liebermann DA, Hoffman B, Steinman RA (1995): Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11:199-210.
61. Lowe SW, Ruley HE, Jacks T, Housman DE (1993): p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74:957-967.
62. Lynch MP, Stein JL, Stein GS, Lian JB (1995): The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216:35-45.
63. Machwate M, Jullienne A, Moukhtar M, Marie PJ (1995): Temporal variation of c-fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing bone. J Cell Biochem 57:62-70.
64. MacKenzie A, Ferguson MWJ, Sharpe PT (1992): Expression patterns of the homeobox gene, Hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape. Development 115:403-420.
65. Maruyama M, Fujita T, Taniguchi T (1989): Sequence of a cDNA coding for human IRF-1. Nucleic Acids Res 17: 3292.
66. Matsumoto H, Debolt K, Shapiro IM (1988): Adenine, guanine, and inosine nucleosides of chick growth cartilage: Relationship between energy status and the mineralization process. J Bone Miner Res 3:347-352.
67. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS (1996): Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of fra-2 and jun D during differentiation. Endocrinology 137:4398-4408.
68. Meikrantz W, Schlegel R (1995): Apoptosis and the cell cycle. J Cell Biochem 58:160-174.
69. Miller AD, Curran T, Verma IM (1984): c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene. Cell 36:51-60.
70. L forms an ion channel in synthetic lipid membranes. Nature 385: 353-357.
71. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993): Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
72. Noble BS, Stevens H, Loveridge N, Reeve J (1997): Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20:273-282.
73. Nossal GJV (1983): Cellular mechanisms of immunologic tolerance. Ann Rev Immunol 1:33-62.
74. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990): Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610.
75. Nurse P (1994): Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
76. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993): Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
77. Oppenheim RW (1984): Naturally occurring cell death during neural development. Trends Neurosci 8:487-493.
78. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990): Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
79. Pandey S, Wang E (1995): Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 58:135-150.
80. Pauli U, Chiu JF, Ditullio P, Kroeger P, Shalhoub V, Rowe T, Stein G, Stein J (1989): Specific interactions of histone H1 and a 45 kilodalton nuclear protein with a putative matrix attachment site in the distal promoter region of a cell cycle-regulated human histone gene. J Cell Physiol 139:320-328.
81. Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB (1992): Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem 49:310-323.
82. Pratt RM, Martin GR (1975): Epithelial cell death and cAMP increase during palatal development. Proc Natl Acad Sci USA 72:874-877.
83. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, Barrett JC (1996): Induction of apoptosis by c-fos protein. Mol Cell Biol 16:211-218.
84. Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC (1990): Rat collagenase: Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 265: 22342-22347.
85. Roach HI, Erenpreisa J, Aigner T (1995): Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol 131:483-494.
86. Rösl F (1992): A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res 20:5243.
87. Saunders JW (1966): Death in embryonic system. Science 154:604-612.
88. Shalhoub V, Jackson ME, Lian JB, Stein GS, Marks SC Jr (1991): Gene expression during skeletal development in three osteopetrotic rat mutations. Evidence for osteoblast abnormalities. J Biol Chem 266:9847-9856.
89. Shapiro IM, Golub EE, Haselgrove JC, Havery J, Chance B, Frasca P (1982): Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science 217:950-952.
90. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH (1994): Premature p34cdc2 activation required for apoptosis. Science 263:1143-1145.
91. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y (1995): Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811-813.
92. Shimizu T, O'Connor PM, Kohn KW, Pommier Y (1995): Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 55:228-231.
93. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI (1993): Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166-169.
94. Soussi T, Caron de Fromentel C, Breugnot C, May E (1988): Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res 16:11384.
95. Tabin C (1995): The initiation of the limb bud: growth factors, hox genes, and retinoids. Cell 80:671-674.
96. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S, Taniguchi T (1995): An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376:596-599.
97. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi T (1994): Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839.
98. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T (1996): Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816-818.
99. Tang K-T, Capparelli C, Stein JL, Stein GS, Lian JB, Huber AC, Braverman LE, DeVito WJ (1996): Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: Altered expression of collagenase, cell growth-related and mineralization-associated genes. J Cell Biochem 61: 152-166.
100. Taniguchi T, Harada H, Lamphier M (1995): Regulation of the interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 121:516-520.
101. Towler DA, Rutledge SJ, Rodan GA (1994): Msx-2/Hox 8.1: A transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 8:1484-1493.
102. Vaughan PS, Aziz F, van Wijnen AJ, Wu S, Harada H, Taniguchi T, Soprano KJ, Stein JL, Stein GS (1995): Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 377:362-365.
103. Vogelstein B, Kinzler KW (1992): p53 function and dysfunction. Cell 70:523-526.
104. Wagner AJ, Small MB, Hay N (1993): Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol 13:2432-2440.
105. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JHV (1993): A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7-12.
106. Yamada G, Ogawa M, Akagi K, Miyamoto H, Nakano N, Itoh S, Miyazaki J, Nishikawa S, Yamamura K, Taniguchi T (1990): Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci USA 88:532-536.
107. Yamamoto H, Lamphier MS, Fujita T, Taniguchi T, Harada H (1994): The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene 9:1423-1428.
108. Zernik J, Thiede MA, Twarog K, Stover ML, Rodan GA, Upholt WB, Rowe DW (1990): Cloning and analysis of the 5′ region of the rat bone/liver/kidney/placenta alkaline phosphatase gene. A dual-function promoter. Matrix 10: 38-47.
109. Zimmerman B (1992): Degeneration of osteoblasts involved in intramembranous ossification of fetal rat calvaria. Cell Tissue Res 267:75-84.